Clinical Trial Supplies Market by Phase, Туре, Product, Therapeutic Area, End User

List of Tables

[187 Pages Report] The Clinical Trial Supplies Market size was estimated at USD 3.35 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 8.43% to reach USD 5.92 billion by 2030.

Global Clinical Trial Supplies Market

KEY MARKET STATISTICS
Base Year [2023]	USD 3.35 billion
Estimated Year [2024]	USD 3.64 billion
Forecast Year [2030]	USD 5.92 billion
CAGR (%)	8.43%

Clinical trial supplies are a fundamental yet complex component of clinical research, ultimately helping pave the way toward successful therapeutic breakthroughs and monumental enhancements in patient care pathways. These supplies cater to various research phases, from pre-clinical examinations to post-marketing surveillance studies, thus facilitating the seamless management and execution of clinical investigations. The increasing prevalence of infectious and chronic diseases worldwide and the subsequent rise in clinical trials with research and development expenditure of the pharmaceutical and biopharmaceutical industry stimulates market growth. The high cost associated with clinical trial supplies, stringent regulations for supplies, and cross-border logistics challenges restrict market growth. Growing emphasis on drug development and shifting towards patient-centric clinical trials offer the potential for better clinical trial patient recruitment, study enrollment, and participant retention. In addition, ongoing advancements in a diverse range of clinical trial supplies are expected to open new research avenues for pharmaceutical and biopharmaceutical companies.

Regional Insights

In the Americas, primarily the United States and Canada, there is a significant dependence on clinical trial supplies due to a high diagnosis rate of chronic diseases and robust healthcare infrastructure. Over the past year, the major patents registered revolved around optimizing supply chain models and employing advanced analytics to align trial supply with demand. The European Union (EU), the Middle East, and Africa exhibit a diverse range of needs due to discrepancies in healthcare access and spending. Europe witnesses steady demand for clinical trial supplies, fueled by heavy investments in research and development initiatives and a surge in the geriatric population. In contrast, Middle Eastern and African countries encompass emerging markets with rising research activities yet laid back due to limited funding and infrastructural impediments. Asia-Pacific, including China, Japan, and India, reports a high disease prevalence, bridged by substantial investments in improving healthcare infrastructure. The booming pharmaceutical industry drives the clinical trial supplies market in these regions, and the demand is dictated more by cost-efficacy rather than speed, mirroring their unique healthcare economic dynamics.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Supplies Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Supplies Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Almac Group Limited, B. Braun SE, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cardinal Health, Inc., Charles River Laboratories, Inc., COREX LOGISTICS LIMITED, Emsere B.V by Medicapital Holdco B.V., Eppendorf SE, Evident Corporation by Olympus Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Group, Hipro Biotechnology Co., Ltd., Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Immudex ApS, Incyte Corporation, IQVIA Inc., Johnson & Johnson Services, Inc., KLIFO A/S, Labnet International, Leica Microsystems GmbH by Danaher Corporation, llumina, Inc., Lonza Group Ltd., Medline Industries, LP, Merck KGaA, Myonex, LLC, Novo Nordisk A/S, Nuvisan GmbH, Parexel International Corporation, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, PerkinElmer Inc. by Revvity, Inc., Pfizer Inc., Promega Corporation, Recipharm AB, Rubicon Research Pvt. Ltd., Sekisui Diagnostics Group, Sharp Services, LLC, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific Inc., and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

Phase
- Phase I
- Phase II
- Phase III
- Phase IV
Type Biologic Drugs
- Medical Devices
- Small-Molecules
Product
- Auxiliary Medicinal Products
- Interactive Response Technology (IRT) solutions
- Lab Supplies
  - Centrifuges
  - Microscopes
  - Pipettes
  - Reagents
- Medical Devices & Diagnostics
- Pharmacy Supplies
  - Biohazard Bags
  - Compounding Aseptic Isolators
  - Sterilization Equipment
- Research Materials
- Safety Equipment
Therapeutic Area
- Cardiology
- Genetic Diseases
- Immunology
- Infectious Diseases
- Metabolic Disorders
- Neurology
- Oncology
End User
- Contract Research Organisations
- Pharmaceutical & Biotechnology Companies
Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Clinical Trial Supplies Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Supplies Market?

3. What are the technology trends and regulatory frameworks in the Clinical Trial Supplies Market?

4. What is the market share of the leading vendors in the Clinical Trial Supplies Market?

5. Which modes and strategic moves are suitable for entering the Clinical Trial Supplies Market?

Product Code: MRR-E0619F076722

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Clinical Trial Supplies Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
  - 5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
- 5.1.2. Restraints
  - 5.1.2.1. High cost of clinical trial supplies
- 5.1.3. Opportunities
  - 5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
  - 5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
- 5.1.4. Challenges
  - 5.1.4.1. Stringent regulations for clinical trial supplies
5.2. Market Segmentation Analysis
- 5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
- 5.2.2. Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
- 5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
- 5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
- 5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
5.3. Market Trend Analysis
- 5.3.1. Well-established pharmaceutical companies emphasis on increasing the number of clinical trials, propelling the need for clinical trial supplies in the Americas
- 5.3.2. Expanding government initiatives to strengthen the clinical trial capabilities coupled with supportive regulations and standards in the APAC region
- 5.3.3. Increasing number of clinical trials and strong and advanced pharmaceutical sector in the EMEA
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Clinical Trial Supplies Market, by Phase

6.1. Introduction
6.2. Phase I
6.3. Phase II
6.4. Phase III
6.5. Phase IV

7. Clinical Trial Supplies Market, by Type

7.1. Introduction
7.2. Biologic Drugs
7.3. Medical Devices
7.4. Small-Molecules

8. Clinical Trial Supplies Market, by Product

8.1. Introduction
8.2. Auxiliary Medicinal Products
8.3. Interactive Response Technology (IRT) solutions
8.4. Lab Supplies
- 8.5.1. Centrifuges
- 8.5.2. Microscopes
- 8.5.3. Pipettes
- 8.5.4. Reagents
8.5. Medical Devices & Diagnostics
8.6. Pharmacy Supplies
- 8.7.1. Biohazard Bags
- 8.7.2. Compounding Aseptic Isolators
- 8.7.3. Sterilization Equipment
8.7. Research Materials
8.8. Safety Equipment

9. Clinical Trial Supplies Market, by Therapeutic Area

9.1. Introduction
9.2. Cardiology
9.3. Genetic Diseases
9.4. Immunology
9.5. Infectious Diseases
9.6. Metabolic Disorders
9.7. Neurology
9.8. Oncology

10. Clinical Trial Supplies Market, by End User

10.1. Introduction
10.2. Contract Research Organisations
10.3. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supplies Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Clinical Trial Supplies Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supplies Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player
- 14.3.1. Merger & Acquisition
  - 14.3.1.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
  - 14.3.1.2. Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery
  - 14.3.1.3. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
- 14.3.2. Agreement, Collaboration, & Partnership
  - 14.3.2.1. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
  - 14.3.2.2. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
  - 14.3.2.3. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
  - 14.3.2.4. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
- 14.3.3. New Product Launch & Enhancement
  - 14.3.3.1. Thermo Fisher Scientific Launches New Smart Refrigerator Series
  - 14.3.3.2. BD Launches New Robotic System to Automate Clinical Flow Cytometry
- 14.3.4. Investment & Funding
  - 14.3.4.1. Experic Closes USD 14 Million Series B Financing
  - 14.3.4.2. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability
- 14.3.5. Award, Recognition, & Expansion
  - 14.3.5.1. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords

15. Competitive Portfolio

15.1. Key Company Profiles
- 15.1.1. 3M Company
- 15.1.2. Abbott Laboratories
- 15.1.3. Almac Group Limited
- 15.1.4. B. Braun SE
- 15.1.5. Baxter International, Inc.
- 15.1.6. Bayer AG
- 15.1.7. Becton, Dickinson and Company
- 15.1.8. Bio-Rad Laboratories, Inc.
- 15.1.9. Bruker Corporation
- 15.1.10. Cardinal Health, Inc.
- 15.1.11. Charles River Laboratories, Inc.
- 15.1.12. COREX LOGISTICS LIMITED
- 15.1.13. Emsere B.V by Medicapital Holdco B.V.
- 15.1.14. Eppendorf SE
- 15.1.15. Evident Corporation by Olympus Corporation
- 15.1.16. F. Hoffmann-La Roche Ltd.
- 15.1.17. Fujifilm Group
- 15.1.18. Hipro Biotechnology Co., Ltd.
- 15.1.19. Hitachi, Ltd.
- 15.1.20. HORIBA, Ltd.
- 15.1.21. ICON PLC
- 15.1.22. Immudex ApS
- 15.1.23. Incyte Corporation
- 15.1.24. IQVIA Inc.
- 15.1.25. Johnson & Johnson Services, Inc.
- 15.1.26. KLIFO A/S
- 15.1.27. Labnet International
- 15.1.28. Leica Microsystems GmbH by Danaher Corporation
- 15.1.29. llumina, Inc.
- 15.1.30. Lonza Group Ltd.
- 15.1.31. Medline Industries, LP
- 15.1.32. Merck KGaA
- 15.1.33. Myonex, LLC
- 15.1.34. Novo Nordisk A/S
- 15.1.35. Nuvisan GmbH
- 15.1.36. Parexel International Corporation
- 15.1.37. Perceptive Informatics LLC and its affiliates, d/b/a Calyx
- 15.1.38. PerkinElmer Inc. by Revvity, Inc.
- 15.1.39. Pfizer Inc.
- 15.1.40. Promega Corporation
- 15.1.41. Recipharm AB
- 15.1.42. Rubicon Research Pvt. Ltd.
- 15.1.43. Sekisui Diagnostics Group
- 15.1.44. Sharp Services, LLC
- 15.1.45. Siemens Healthcare GmbH
- 15.1.46. Smith & Nephew PLC
- 15.1.47. Stryker Corporation
- 15.1.48. Thermo Fisher Scientific Inc.
- 15.1.49. Woodley Equipment Company Ltd.
15.2. Key Product Portfolio

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing